A comparison of health-related factors between patients diagnosed with ME/CFS and patients with a related symptom picture but no ME/CFS diagnosis: A cross-sectional exploratory study

doi:10.21203/rs.3.rs-2068253/v1

Download PDF

Research Article

A comparison of health-related factors between patients diagnosed with ME/CFS and patients with a related symptom picture but no ME/CFS diagnosis: A cross-sectional exploratory study

https://doi.org/10.21203/rs.3.rs-2068253/v1

This work is licensed under a CC BY 4.0 License

You are reading this latest preprint version

Background

In chronic fatigue syndrome/myalgic encephalomyelitis (ME/CFS), the capacity for activity and participation is strongly limited. The disease definition is very broad, and considering the lack of evidence for best treatment, it is important to understand what is ME/CFS-specific in the biopsychosocial perspective in comparison with similar syndromes. The objective was to study the difference between those diagnosed with ME/CFS and those with similar symptoms but no ME/CFS diagnosis for self-perceived level of physical activity, work ability, anxiety/depression, and health-related quality of life.

Methods

This was a clinical cross-sectional study with data collected from mailed questionnaires. The following variables were compared between patients diagnosed with ME/CFS (n=205) and those with similar symptoms but no diagnosis (n=57); level of physical activity, Work ability index (WAI), Hospital anxiety and depression scale (HAD-A/HAD-D), and RAND-36 Physical functioning, Role limitations due to physical health problems, Role limitations due to personal or emotional problems, Social functioning, Energy/fatigue, Bodily pain, Emotional well-being, and General health perceptions. The Chi-squared test (nominal data), the Mann-Whitney U test and the Student’s t test were used to analyze the data.

Results

The group diagnosed with ME/CFS had a more impaired physical and mental exertion ability as compared to the group that had similar symptoms but was not diagnosed with ME/CFS, shown by a RAND-36 lower index of physical role functioning (p = 0.00), social functioning (p=0.00), energy (p = 0.01), worse pain (p = 0.02) and poorer overall health (p = 0.00). In contrast, no significant group differences emerged for weekly level of physical activity, work ability, anxiety/depression, and RAND-36 Emotional role limitation and well-being.

Conclusion

Our results indicate that those with a diagnosis of ME/CFS are characterized by an impaired ability for physical or mental exertion, worse pain, and poorer overall health as compared to individuals with similar symptoms but for whom ME/CFS-diagnosis was not established. The results may be cautiously interpreted as support when focusing on patients' self-care in terms of management of energy levels. The results must however be verified in future studies.

Central nervous system

Chronic pain

Public health

Biopsychosocial models

Patient reported outcome measures

In recent years, chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME), hereinafter referred to as ME/CFS, has been, and continues to be, a debated field [1–3]. In addition to possible pathomechanisms, special attention has been focused on the severely limited activity and restricted participation that follows from the in many cases severe disabilities [4, 5]. ME/CFS involves a persistent lack of energy or persistent pain, and often overwhelming fatigue from simple exertion [5]. Patients with ME/CFS often report that they cannot cope with chores at home, leisure activities or socializing with others [6, 7]. VanElzakker et al. [8] describe the underlying causes of the disease as essentially unknown, even if a substantial part of those who have developed ME/CFS did so after a severe viral or bacterial infection, where healing or recovery did not occur. Some evidence suggests links between central sensitization in ME/CFS and interactions between psychosocial parameters such as depression and level of physical activity [9, 10].

To formulate the diagnosis, the Canadian criteria based on seven symptoms are used: fatigue, exercise-induced deterioration, sleep disturbances, pain, neurological and cognitive symptoms, as well as autonomic, neuroendocrine and immunological symptoms, and the symptoms should have lasted for more than six months [4]. Even though early diagnosis is encouraged, the average time from symptoms to diagnosis is 3.6 years [11]. As a result of this delay, along with the lack of awareness and knowledge, there are reasons to believe that tens of millions in the world have undiagnosed ME/CFS [12]. According to The Swedish National Association for ME Patients (RME), there are about 10.000 people with ME/CFS in Sweden [13].

The definition and the understanding of ME/CFS is challenging. People living with ME/CFS report a feeling of being unsupported or dismissed by health professionals or employers who don't take their symptoms seriously [14]. The pathophysiology of ME/CFS is in the form of neuropathies (dysautonomia and neuropathic pain), of a character or with manifestations that can be psychologized by both caregivers and the patients themselves, often influenced by health care contacts, in cases where the right knowledge is not available [15, 16].

To manage the complexities of patients, a more flexible biopsychosocial approach is recommended [17]. Considering the broad definition of ME/CFS, it would be of interest to define what characterizes those with established ME/CFS diagnosis regarding self-perceived health factors compared to those with a related complex symptom picture who do not have a diagnosis.

The aim of this study was therefore to investigate how patients referred to a specialist clinic for suspicion of ME/CFS, rated several health-related factors: perceived level of physical activity, work ability, anxiety/depression, and health-related quality of life. We also sought to investigate whether the factors differed between patients who met the criteria for ME/CFS diagnosis, and those where ME/CFS diagnosis was not established.

The present work is an explorative clinical study in which participants (n = 277) were consecutively recruited among patients referred from primary care to a specialist ME/CFS clinic for evaluation of ME/CFS.

Patients whose referral were accepted by the specialist clinic were sent questionnaires by mail for a routine initial status (below). An invitation for study participation with research person information and a consent form was included. The mailing and receipt of questionnaires were handled by the receptionists at the clinic independently of the study.

The inclusion criteria were men and women (≥ 18 years) with a suspected ME/CFS diagnosis who were admitted for further investigation at the specialist clinic. No exclusion criteria were used, apart from those applied in the reviews of referrals, such as any clinical condition that would limit the ability to take part in the investigation (e.g. known drug abuse) or limited ability to speak and comprehend the Swedish language.

ME/CFS diagnosis

The final diagnosis was established by the attending physician at the specialist clinic by mapping the patient’s current symptoms, using a structured clinical protocol, according to the Canadian diagnostic criteria for ME/CFS [4]. This included taking a patient history, conducting a physical examination, and evaluating lab tests as well as any differential diagnoses, to rule out other exclusionary diseases.

Instruments

Physical activity

A physical activity questionnaire was used to specify the total time spent on activity during a normal week, for different aspects [18]. The first question asks about time spent on high intensity activity, and the second question deals with moderate intensity; time spent practicing everyday physical activity. Both have fixed answer options (time categories). The results from the two are merged, which generates an outcome of “activity minutes” (recommended level more or equal to 150 activity minutes per week). These questions have been evaluated for psychometric properties and were shown to be equivalent to other self-reported questions about physical activity [18].

Work ability index (WAI)

WAI is primarily used to identify signs of ill health in workers [19]. The instrument has 10 questions in 7 different areas [20, 21]. In the present study, only the first question, WAI 1, was used, for rating one's own current work ability versus one's best during one's lifetime on a scale of 0–10. WAI 1 has been found to be a suitable proxy for the WAI and with acceptable validity [22–24]. With this item, the individual's working capacity can be classified into poor (0–5), moderate (6–7), good (8–9) or excellent (10) working capacity [22].

Hospital anxiety and depression scale (HAD)

HAD has two subscales to obtain a measurement of anxiety symptoms and depressive symptoms (HADS-anxiety/worry, HADS-depressiveness/depression), extensively evaluated for psychometric properties [25, 26]. Each subscale has seven statements, in total 14 claims, all concerning the past week [27–29]. Answers are indicated on a four-point Likert scale (0–3 points). Scoring can thus amount to a maximum of 21 points per subscale. The patient's sum score shows any of three "severity levels": small, moderate, or high risk to have a depression or anxiety of clinical significance. A cut value of 8 has been shown to be the most optimal for detection while having sufficient specificity [25, 26]. Participants who have 11 points or more on a subscale are likely to have a condition of clinical significance [26]. Scores between 15 and 21 indicate a severe anxiety or depression. We used the individual's subscale means to replace missing scores, provided no more than 2 items of a subscale were missing [30].

RAND-36

RAND-36 is used for forming a deeper understanding of how people living with a condition assess and adapt to their health situation [31, 32]. RAND-36 was formerly called SF-36 (Short Form − 36), which was developed in the United States by the RAND corporation within the” Medical Outcomes Study” (MOS), to reflect the World Health Organization’s (WHO) definition of health.

RAND-36 consists of 36 multiple choice questions spread over eight sub-scales and has adequate measurement properties [31, 33]. The eight subscales are Physical functioning, Role limitations due to physical health problems, Role limitations due to personal or emotional problems, Social functioning, Energy/fatigue, Bodily pain, Emotional well-being, and General health perceptions, and each generate an overall index of 0–100%, where 100% represents excellent health. (Emotional well-being and energy/fatigue have been used interchangeably with general mental health and vitality, respectively). Compared with how the SF-36 is scored, the scoring differs for two domains: Role limitations due to physical health problems and Role limitations due to emotional problems, with 5-point response choices in RAND-36 instead of option yes/no. Items that were left blank (missing data) were not taken into account when calculating the scale scores [34]. Hence, scale scores represent the average for all items in the scale that the respondent answered. We allowed 1 missing item per subscale [34].

Statistical analysis

Data was summarized with descriptive statistics and presented with median (range), mean (standard deviation) frequency and percentages. Missing cases were reported as such for each variable and not included in the analyses.

The Mann-Whitney U test (range data) was used to test the null hypothesis for ordinal data, that there was no difference between the group diagnosed with ME/CFS compared to the group who did not receive this diagnosis [35]. Parametric tests were used for age and physical activity minutes. The Shapiro-Wilks test was used to test for normality [36].

No power calculation was performed as the study was considered to be explorative. The predefined research project sample size of 270 participants was however considered adequate. This was based on an estimated required minimum of approximately 100 participants on expected approximate averages and standard deviations of measurements for the included instruments and taking into account some loss of data.

All data analyses were done in R version 4.1.1 [37]. The significance level was set at p ≤ 0.05. P-values were adjusted for multiplicity using the Holm method [38]. Both original and adjusted p-values are presented. Conclusions were based on the adjusted p-values.

A total of 277 patients were eligible for this study. For fifteen patients, the investigation was prematurely suspended due to changed priorities in the patients’ situations (e.g. to move elsewhere). The study group thus comprised 262 patients, of whom 205 (78%) were diagnosed with ME /CFS at the specialist clinic. The amount of missing data was < 10% for all variables (mixed item/unit non-response and lost files), as follows: 8 cases for the physical activity questions, 7 cases for the WAI, 6/6 cases for the sections on anxiety/depression. Regarding the RAND-36, it was not completed by 17 patients (Table 1).

Characteristics of the diagnosed and undiagnosed group are presented in Table 1, together with median values of the self-reported level of physical activity, work ability, anxiety and depression, and health-related quality of life. Results showed significantly worse ratings in the group that was diagnosed with ME/CFS for the following RAND-36 outcome measures: decreased physical role functioning (p = 0.00) and vitality (energy/fatigue) (p = 0.01); decreased social functioning (p = 0.03); worse pain (p = 0.02); and lower general health perceptions (p = 0.00) (Fig. 1).

No between group differences were found for physical activity level, work ability, anxiety and depression, and for the RAND-36 role limitations due to personal or emotional problems, and emotional well-being.

Table 1

Characteristics of the study participants (n = 262) and group differences between those with and without a ME/CFS diagnosis for the measured variables.
	Diagnosed ME/CFS (n = 205)	Undiagnosed (n = 57)	Missing cases. n (diagnosed /undiagnosed)	p	Adjusted p
Gender (men/women), n (%)	25/180 (12/88)	18/39 (32/68)	-	0.00	0.01
Age (years), Mean (SD)	45 (11)	49 (14)	-	0.03	0.18
Physical activity Activity minutes weekly Mean (SD)	109 (107)	150 (141)	8 (6/2)	0.05	0.28
Work ability WAI score (0–10) *#	1.0 (0.0–3.0) 1.6 (1.9)	2.0 (0.0–4.5) 2.6 (2.5)	7 (5/2)	0.01	0.11
Anxiety HAD-Anxiety (0–21) *#	7 (3–11) 7.5 (4.8)	7 (4–9) 6.9 (4.3)	6 (6/0)	0.39	1.00
Depression HAD-Depression (0–21) *#	9 (6–13) 9.3 (4.7)	8 (6–11) 8.7 (4.5)	6 (6/0)	0.31	1.00
RAND-36
Physical functioning (0-100) *#	40 (25–55) 40.3 (21.1)	45 (35–62) 48.9 (22.0)	15 (10/5)	0.02	0.16
Role limitations due to physical health problems (0-100) *#	0 (0.–0.0) 1.2 (6.9)	0.0 (0.0–0.0) 9.8 (25.5)	16 (10/6)	0.00	0.00
Role limitations due to personal or emotional problems (0-100) *#	67 (0–100) 56 (45.4)	67 (0–100) 57 (44.3)	17 (11/6)	0.78	1.00
Social functioning (0-100) *#	25 (0–25) 21.3 (18.5)	25 (13–44) 32.0 (23.9)	8 (6/2)	0.00	0.03
Energy/fatigue (0-100) *#	5 (0–15) 10.3 (12.0)	10 (5–27.5) 19.4 (20.8)	6 (4/2)	0.00	0.01
Bodily pain (0-100) *#	23 (10–45) 30.7 (23.5)	45 (23–55) 41.4 (25.8)	7 (5/2)	0.00	0.02
Emotional well-being (0-100) *#	60 (44–76) 57.9 (21.5)	68 (44–76) 59.8 (22.4)	6 (4/2)	0.40	1.00
General health perceptions (0-100) *#	20 (15–30) 22.9 (13.6)	30 (20–43.8) 32.54 (17.5)	9 (6/3)	0.00	0.00
ME/CFS = myalgic encephalomyelitis/chronic fatigue syndrome. HAD = Hospital anxiety and depression scale. WAI = Work ability index. Q1–Q3 = First and third interquartile range, SD = Standard deviation * Mdn (Q1-Q3) # Mean (SD)

Measuring of the various health-related factors showed that the group diagnosed with ME/CFS distinguished itself compared to the group of individuals for whom an ME/CFS-diagnosis was not established by an impaired ability for physical or mental effort (measurements of physical and social functioning, and energy), worse pain and worse general health. No significant between-group differences were however found regarding assessed activity minutes per week, work ability, anxiety/depression, emotional role limitation and well-being.

The findings of impaired physical ability being characteristic in ME/CFS are, as could be expected, in accordance with previous studies [39]. A few previous studies have used the RAND-36 and indicated a slightly better self-perceived health among participants with ME/CFS than in the present study [40–42]. We reflect that this may in part be an effect of the broad diagnostic criteria for ME/CFS; one study had a group who met the Oxford criteria [40], and the other, both the Fukuda and Canada criteria [41]. The results of the present study support the role of the RAND-36 subscales Physical role limitation and Social functioning in the diagnostics of ME/CFS, as it showed outcomes that were consistent with the divide in the assessment where the diagnosis was or was not given. This was also acknowledged in a previous American study with a comparable population (70% women, average age 50 years) who met both the Fukuda and Canada criteria [43]. The authors recommended these sub-scales, as well as the sub-scale Physical functioning, for identifying the cardinal ME/CFS symptoms of impaired physical and mental ability [43].

The scoring of emotional or psychological ill-health (measurements of anxiety/depression, and emotional role limitations and well-being) reported in the present study was at the lower end (equals better health status) of reports in previous studies of the same population, which showed mean HAD-anxiety score 10.0 and mean HAD-depression 8.9 [44], while a study with patients with fibromyalgia [45] showed median HAD-anxiety 10.6 och HAD-depression 9.9. Surprisingly, no differences were found in our study between the diagnosed and the undiagnosed group regarding anxiety/depression, emotional well-being and emotional role limitation, so presumably none of these factors should have had an impact on the particularly low perceived energy level seen within the ME/CFS Group.

Central sensitization has been considered to be a common denominator or a main feature of chronic fatigue and associated conditions, such as whiplash associated disorders, but with different degree of severity, with ME/CFS placed at the far end of the scale and thus characterized by pronounced central sensitization [46]. Post-exertional malaise (PEM) is a manifestation of central sensitization [46]. Wormgoor et al. discuss the related diagnostic concepts and propose to define "ME" with post-exertional malaise (PEM) being included as a cardinal symptom, "CFS" with PEM occurring to varying degrees, and "chronic fatigue" with not including PEM [47]. The present study suggests a support for such a division of diagnoses.

Considering what would be the underlying mechanisms of the eroded physical functioning and energy in ME/CFS raises questions about this group’s pattern of activities of daily living and recovery. We hypothesize that a difficult combination of two precipitating factors could act in the development and maintenance of the disease in many cases. Firstly, an imbalance of activity–recovery being present in those diagnosed with ME/CFS leading to chronic physiological stress and a secondary dysautonomia as suggested by Martínez-Martínez [48]. There may be difficulties in completing activities, where the person has tried to perform activities based on old habits and routines such as before the illness, and difficulty managing energy levels [6]. One reason for this could be that the phenotype with overly elastic connective tissue is overrepresented in ME/CFS [49] and often accompanied by decreased interoceptive ability (ability to read, interpret and adapt to bodily signals) [50–54]. Secondly, a greater exposure from persistent negative psychosocial stress especially in ME/CFS, where the often-unexplained symptoms of ME/CFS may cause a notion of one’s well-being as unpredictable and out of control, leading to feelings of, among others, insecurity and a dependency on external circumstances [55]. A telling example is of recommendations from health care professionals to engage in general physical exercise, without the required adaptation of the training dose, where ME/CFS was not seriously considered as a diagnosis. This usually leads to exacerbation [56, 57]. Thus, the trust in one's own abilities is undermined, with far-reaching, likely incalculable consequences.

According to clinical experience, this unfortunate combination is not seldom a challenge for patients with ME/CFS that can act detrimental to well-being. Not least does this apply to the illness’ traits pain and fatigue, since the body's response to long-term stress includes the hypothalamic-pituitary-adrenal (HPA) axis being activated to affect nociception and with central sensitivity syndromes as a result [58, 59].

It is recommended for patients with ME/CFS and caregivers to work together to explore best practices [12, 17]. A biopsychosocial or holistic approach is part of the main recommendations in guidelines for ME/CFS [39]. The praxis, however, of a biopsychosocial management in ME/CFS is at the horizon, partly because of well-functioning multiprofessional teams not always being accessible in the primary health care system to which patients with ME/CFS are generally affiliated [60]. Also, many patient representatives have historically voiced a demand for development of the biomedical type of treatments in particular [61]. Finally, the mode of treatment of pacing or activity management needs to be further researched.

We used several PROMs to measure the health-related factors. The PROMs are commonly used in primary and secondary care in Sweden for various types of pain disorders and the outcomes are registered and followed up nationally in a quality registry of pain rehabilitation [62]. PROMs used in the assessment of ME/CFS are suggested to have some need for development, mainly to be made more relevant for the patient group [63]. Of the PROMs used in this study, only the HAD has been evaluated for its applicability among adults with suspected ME/CFS and was found suitable for this group of patients [64, 65].

A strength with this study is that it sheds light on the disease entity of ME/CFS. Self-perceived health has been extensively studied for various diseases, although to a relatively small extent for ME/CFS. Moreover, as far as we the authors are aware, this is the first study to compare diagnosed cases with ME/CFS and those with similar symptoms but no ME/CFS diagnosis from the same population. The results should, however, be interpreted in the light of the study’s limitations, first and foremost the cross-sectional nature of the study, and in which data was collected through patient-reported questionnaires. The group diagnosed with ME/CFS had a higher percentage of women than the undiagnosed group. If the groups would have been matched with respect to gender, the differences between the groups might have appeared otherwise since women, as a rule, have pain to a greater extent than men. Another limitation is that the diagnosis of ME/CFS was established from the recommended Canada criteria but also from subjective assessments depending on the experience of assessors that should be taken into consideration.

CFS Chronic fatigue syndrome

HAD Hospital anxiety and depression scale

Mdn Median

ME Myalgic encephalomyelitis

Q1–Q3 First and third interquartile range

SD Standard deviation

WAI Work ability index

Ethics approval and consent to participate

All included patients gave their written consent to participate in the study (Swedish Ethical Review Authority registration number 2022-00868-02).

Consent for publication

Not applicable

Availability of data and materials

The datasets used and analysed during the current study are available from the corresponding author on reasonable request.

Competing interests

The authors declare that they have no competing interests.

Funding

This research received no grants from the public, commercial, or not-for-profit sectors.

Authors' contributions

The authors confirm contribution to the paper as follows: Study design: ERB, GB and LBK. Data collection: GB. Analysis and interpretation of results: GB. Draft manuscript preparation: GB. ERB and LBK reviewed the results and all authors revised and approved the final manuscript.

Acknowledgements

The authors thank the patients participating in the study and the staff of Bragée ME Centre for their valued contributions.

Authors' information (optional)

Not applicable

Hooge J. Chronic fatigue syndrome: cause, controversy and care. Br J Nurs. 1992;1(9):440–6. doi:10.12968/bjon.1992.1.9.440.
Pilkington K, Ridge DT, Igwesi-Chidobe CN, et al. A relational analysis of an invisible illness: A meta-ethnography of people with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and their support needs. Soc Sci Med. 2020;265:113369.
Marsh S. ME exercise therapy guidance scrapped by health watchdog Nice [Internet]. London, United Kingdom: The Guardian; 2021 [updated 2021; cited 2022 May 22]. Available from: https://www.theguardian.com/society/2021/oct/29/health-watchdog-nice-publishes-delayed-me-guidance?CMP=Share_iOSApp_Other.
Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, Staines D, Powles ACP, Speight N, Vallings R, Bateman L, Baumgarten-Austrheim B, Bell DS, Carlo-Stella N, Chia J, Darragh A, Jo D, Lewis D, Light AR, Marshall-Gradisnik S, Mena I, Mikovits JA, Miwa K, Murovska M, Pall ML, Stevens S. Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med. 2011 Oct;270(4):327–38. doi:10.1111/j.1365-2796.2011.02428.x.
CDC. Myalgic encephalomyelitis/chronic fatigue syndrome [Internet]. [Atlanta, GA: Centers for Disease Control and Prevention]; Updated 2022 April 22; cited 2022 May 22]. Available from: https://www.cdc.gov/me-cfs/index.html.
Kos D, van Eupen I, Meirte J, Van Cauwenbergh D, Moorkens G, Meeus M, Nijs J. Activity pacing self-management in chronic fatigue syndrome: A randomized controlled trial. Am J Occup Ther. 2015;69(5):6905290020p1–11. doi:10.5014/ajot.2015.016287.
Vos-Vromans DCWM, Smeets RJEM, Huijnen IPJ, Köke AJA, Hitters WMGC, Rijnders LJM, Pont M, Winkens B, Knottnerus JA. Multidisciplinary rehabilitation treatment versus cognitive behavioural therapy for patients with chronic fatigue syndrome: a randomized controlled trial. J Intern Med. 2016 Mar;279(3):268–82. doi:10.1111/joim.12402.
VanElzakker MB, Brumfield SA, Mejia PSL. Neuroinflammation and Cytokines in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Critical Review of Research Methods. Front Neurol. 2019 Jan 10;9:1033. doi: 10.3389/fneur.2018.01033.
Nijs J, Van de Putte K, Louckx F, Truijen S, De Meirleir K. Exercise performance and chronic pain in chronic fatigue syndrome: the role of pain catastrophizing. Pain Med. 2008 Nov;9(8):1164–72. doi:10.1111/j.1526-4637.2007.00368.x.
Meeus M, Nijs J, Van Mol E, Truijen S, De Meirleir K. Role of psychological aspects in both chronic pain and in daily functioning in chronic fatigue syndrome: a prospective longitudinal study. Clin Rheumatol. 2012 Jun;31(6):921–9. doi:10.1007/s10067-012-1946-z.
Weardon AJ, Dowrick C, Chew-Graham C, Bentall RP, Morriss RK, Peters S, Riste L, Richardson G, Lovell K, Dunn G. Nurse led, home based self help treatment for patients in primary care with chronic fatigue syndrome: randomised controlled trial. Br Med J. 2010;340:c1777.
US Institute of Medicine. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: redefining an illness. Washington, DC: The National Academies Press; 2015. https://doi.org/10.17226/19012.
RME. Myalgic encephalomyelitis/chronic fatigue syndrome [Internet]. [Stockholm, Sweden: Riksförbundet för ME-patienter]; Cited 2022 May 22]. Available from: https://rme.nu/om-me-cfs/.
Chew-Graham C, Dixon R, Shaw JW, Smyth N, Lovell K, Peters S. Practice nurses' views of their role in the management of chronic fatigue syndrome/myalagic encephalitis: a qualitative study. BMC Nurs. 2009 Jan 22;8:2. doi: 10.1186/1472-6955-8-2.
Shaw BH, Stiles LE, Bourne K, Green EA, Shibao CA, Okamoto LE, Garland EM, Gamboa A, Diedrich A, Raj V, Sheldon RS, Biaggioni I, Robertson D, Raj SR. The face of postural tachycardia syndrome - insights from a large cross-sectional online community-based survey. J Intern Med. 2019 Oct;286(4):438–48. doi:10.1111/joim.12895.
Bernhoff G, Saripanidis C, Bertilson BC. “As if neck injuries did not exist”: an interview study of patients’ and relatives’ perceptions of web information on and management of whiplash injuries in Sweden. Interact J Med Res. 2019 Apr-Jun; 8(2): e9881. doi: 10.2196/ijmr.9881.
Bayliss K, Goodall M, Chisholm A, et al. Overcoming the barriers to the diagnosis and management of chronic fatigue syndrome/ME in primary care: a meta synthesis of qualitative studies. BMC Fam Pract. 2014;15:1–11.
Olsson SJG, Ekblom Ö, Andersson E, Börjesson M, Kallings LV. Categorical answer modes provide superior validity to open answers when asking for level of physical activity: a cross-sectional study. Scand J Public Health. 2016 Feb;44(1):70–6. doi:10.1177/1403494815602830.
Tuomi K, Ilmarinen J, Martikainen R, Aalto L, Klockars M. Aging, work, life-style and work ability among Finnish municipal workers in 1981–1992. Scand J Work Environ Health. 1997;23:58–65.
de Zwart BCH, Frings-Dresen MHW, van Duivenbooden JC. Test-retest reliability of the Work Ability Index questionnaire. Occup Med (Lond). 2002 Jun;52(4):177–81. doi:10.1093/occmed/52.4.177.
Roelen CA, van Rhenen W, Groothoff JW, van der Klink JJ, Twisk JW, Heymans MW. Work ability as prognostic risk marker of disability pension: single-item work ability score versus multi-item work ability index. Scand J Work Environ Health. 2014 Jul;40(4):428–31. doi:10.5271/sjweh.3428.
Ahlstrom L, Grimby-Ekman A, Hagberg M, Dellve L. The work ability index and single-item question: associations with sick leave, symptoms, and health – a prospective study of women on long-term sick leave. Scand J Work Environ Health 2010, Sept 36(5):404–12.
Lundin A, Leijon O, Vaez M, Hallgren M, Torgén M. Predictive validity of the Work Ability Index and its individual items in the general population. Scand J Public Health. 2017 Jun;45(4):350–356. doi: 10.1177/1403494817702759.
Ebener M, Hasselhorn HM. Validation of short measures of work ability for research and employee surveys. Int J Environ Res Public Health. 2019 Sep;16(18):3386. doi:10.3390/ijerph16183386.
Bjelland I, Dahl AA, Tangen Haug T, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002 Feb;52(2):69–77. doi:10.1016/s0022-3999(01)00296-3.
Brehaut E, Neupane D, Levis B, Wu Y, Sun Y, Krishnan A, et al. Depression prevalence using the HADS-D compared to SCID major depression classification: An individual participant data meta-analysis. J Psychosom Res. 2020 Dec;139:110256. doi: 10.1016/j.jpsychores.2020.110256.
Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta psychiatrica Scandinavica. 1983;67:361–70.
Lisspers J, Nygren A, Söderman E. Hospital anxiety and depression scale (HAD): some psychometric data for a Swedish sample. Acta psychiatrica Scandinavica. 1997;96(4):281–6.
Snaith RP. (2003). The Hospital Anxiety And Depression Scale. Health and Quality of Life Outcomes, 1(1), 29. doi10.1186/1477-7525-1-29.
Bell ML, Fairclough DL, Fiero MH, Butow PN. Handling missing items in the Hospital Anxiety and Depression Scale (HADS): a simulation study. BMC Res Notes. 2016;9:479. doi:10.1186/s13104-016-2284-z.
Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ. 1993 Oct;2(3):217–27. doi: 10.1002/hec.4730020305.
Orwelius L, Nilsson M, Nilsson E, Wenemark M, Walfridsson U, Lundström M, Taft C, Palaszewski B, Kristenson M. The Swedish RAND-36 Health Survey: reliability and responsiveness assessed in patient populations using Svensson's method for paired ordinal data. J Patient Rep Outcomes. 2017;2(1):4. doi:10.1186/s41687-018-0030-0.
Ohlsson-Nevo E, Hiyoshi A, Norén P, Möller M, Karlsson J. The Swedish. RAND-36: psychometric characteristics and reference data from the Mid-Swed Health Survey. J Patient Rep Outcomes. 2021 Aug 4;5(1):66. doi: 10.1186/s41687-021-00331-z.
Rand Corporation. 36-Item Short form survey (SF-36) scoring instructions [Internet]. [Santa Monica, CA: Rand Corporation]; cited 2022 August 5]. Available from: https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form/scoring.html.
Mann HB, Whitney DR. On a test of whether one of two random variables is stochastically larger than the other. Ann Math Statist. 1947;18(1):50–60. doi:10.1214/aoms/1177730491.
Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika. 1965;52(3–4):591–611.
R Core Team. (2021). R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/.
Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6(2):65–70.
National Institute for Health and Care Excellence (NICE). Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management NICE guideline [NG206] [Internet]. [London, UK: National Institute for Health and Care Excellence]; Cited 2022 August 8. Available from: https://www.nice.org.uk/guidance/NG206 (accessed 11 August 2022).
Maher-Edwards L, Fernie BA, Murphy G, Wells A, Spada MM. Metacognitions and negative emotions as predictors of symptom severity in chronic fatigue syndrome. J Psychosom Res. 2011 Apr;70(4):311–7. doi: 10.1016/j.jpsychores.2010.09.016.
van Campen CLM, Riepma K, Visser FC. Open trial of vitamin B12 nasal drops in adults with myalgic encephalomyelitis/chronic fatigue syndrome: comparison of Responders and Non-Responders. Front Pharmacol. 2019 Sep 20;10:1102. doi: 10.3389/fphar.2019.01102.
King E, Beynon M, Chalder T, Sharpe M, White PD. Patterns of daytime physical activity in patients with chronic fatigue syndrome. J Psychosom Res. 2020 Aug;135:110154. doi: 10.1016/j.jpsychores.2020.110154.
de Vega WC, Erdman L, Vernon SD, Goldenberg A, O McGowan P. Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome. Epigenomics. 2018 May;10(5):539–557. doi: 10.2217/epi-2017-0150.
Daniels J, Brigden A, Kacorova A. Anxiety and depression in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): Examining the incidence of health anxiety in CFS/ME. Psychol Psychother. 2017 Sep;90(3):502–509. doi: 10.1111/papt.12118.
Celepkolu T, Gamze Erten Bucaktepe P, Yilmaz A, Pervane VD, Batmaz I, Sariyildiz MA. Assessment of quality of life, anxiety, depression, and sleep quality in women with fibromyalgia and their spouses. Eur Rev Med Pharmacol Sci. 2021 Jul;25(13):4506–13. doi:10.26355/eurrev_202107_26242.
Nijs J, Meeus M, Van Oosterwijck J, Ickmans K, Moorkens G, Hans G, De Clerck LS. In the mind or in the brain? Scientific evidence for central sensitisation in chronic fatigue syndrome. Eur J Clin Invest. 2012 Feb;42(2):203–12. doi:10.1111/j.1365-2362.2011.02575.x.
Wormgoor MEA, Rodenburg SC. The evidence base for physiotherapy in myalgic encephalomyelitis/chronic fatigue syndrome when considering post-exertional malaise: a systematic review and narrative synthesis. J Transl Med. 2021 Jan 4;19(1):1. doi: 10.1186/s12967-020-02683-4.
Martínez-Martínez L-A, Mora T, Vargas A, Fuentes-Iniestra M, Martínez-Lavín M. Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: a review of case-control studies. J Clin Rheumatol. 2014 Apr;20(3):146–50. doi:10.1097/RHU.0000000000000089.
Hakim A, De Wandele I, O'Callaghan C, Pocinki A, Rowe P. Chronic fatigue in Ehlers-Danlos syndrome-Hypermobile type. Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):175–80. doi:10.1002/ajmg.c.31542.
Craig AD. How do you feel? Interoception: the sense of the physiological condition of the body. Nat Reviews Neurosci volume. 2002;3:pages655–666.
Haase L, Stewart JL, Youssef B, May AC, Isakovic S, Simmons AN, Johnson DC, Potterat EG, Paulus MP. When the brain does not adequately feel the body: Links between low resilience and interoception. Biol Psychol. 2016 Jan;113:37–45. doi: 10.1016/j.biopsycho.2015.11.004.
Maroti D, Molander P, Bileviciute-Ljungar I. Differences in alexithymia and emotional awareness in exhaustion syndrome and chronic fatigue syndrome. Scand J Psychol. 2017 Feb;58(1):52–61. doi:10.1111/sjop.12332.
Kiraz S, Sertçelik S, Taycan SE. The relationship between alexithymia and impulsiveness in adult attention deficit and hyperactivity disorder. Turk Psikiyatri Derg Summer. 2021;32(2):109–17. doi:10.5080/u23775.
Glans M, Thelin N, Humble MB, Elwin M, Bejerot S. Association between adult attention-deficit hyperactivity disorder and generalised joint hypermobility: A cross-sectional case control comparison. J Psychiatr Res. 2021 Nov;143:334–340. doi: 10.1016/j.jpsychires.2021.07.006.
Kilic SA, Dorstyn DS, Guiver NG. Examining factors that contribute to the process of resilience following spinal cord injury. Spinal Cord. 2013 Jul;51(7):553–7. doi:10.1038/sc.2013.25.
Baraniuk JN, Shivapurkar N. Exercise—Induced changes in cerebrospinal fluid miRNAs in Gulf War Illness, Chronic Fatigue Syndrome and sedentary control subjects. Sci Rep. 2017;7:15338. doi:10.1038/s41598-017-15383-9.
Van Oosterwijck J, Nijs J, Meeus M, Van Loo M. Paul L. Lack of endogenous pain inhibition during exercise in people with chronic whiplash associated disorders: An experimental study. J Pain. 2012;13:242–54. doi:10.1016/j.jpain.2011.11.006.
Eller-Smith OC, Nicol AL, Christianson JA. Potential mechanisms underlying centralized pain and emerging therapeutic interventions. Front Cell Neurosci. 2018 Feb 13;12:35. doi: 10.3389/fncel.2018.00035.
Colgan DD, Eddy A, Green K, Oken B. Adaptive body awareness predicts fewer central sensitization-related symptoms and explains relationship between central sensitization-related symptoms and pain intensity: A cross-sectional study among individuals with chronic pain. Pain Pract. 2022 Feb;22(2):222–32. doi:10.1111/papr.13083.
van Dijk-de Vries A, Moser A, Mertens VC, et al. The ideal of biopsychosocial chronic care: How to make it real? A qualitative study among Dutch stakeholders. BMC Fam Pract. 2012;13:14. https://doi.org/10.1186/1471-2296-13-14.
Rehmeyer J. Bad science misled millions with chronic fatigue syndrome. Here’s how we fought back. Stat [Internet]. 2016 Sept 21 [cited 2022 Aug 11]. Available from: https://www.statnews.com/2016/09/21/chronic-fatigue-syndrome-pace-trial/.
Rivano Fischer M, Schults M-L, Stålnacke B-M, Ekholm J, Persson EB, Löfgren M. Variability in patient characteristics and service provision of interdisciplinary pain rehabilitation: A study using the Swedish national quality registry for pain rehabilitation. J Rehabil Med. 2020 Nov 27;52(11):jrm00128. doi: 10.2340/16501977-2765.
Haywood KL, Staniszewska S, Chapman S. Quality and acceptability of patient-reported outcome measures used in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review. Qual Life Res. 2012 Feb;21(1):35–52. doi: 10.1007/s11136-011-9921-8.
McCue P, Buchanan T, Martin CR. Screening for psychological distress using internet administration of the Hospital Anxiety and Depression Scale (HADS) in individuals with chronic fatigue syndrome. Br J Clin Psychol. 2006 Nov;45(Pt 4):483–98. doi:10.1348/014466505X82379.
Henderson M, Tannock C. Use of depression rating scales in chronic fatigue syndrome. J Psychosom Res. 2005 Sep;59(3):181–4. doi: 10.1016/j.jpsychores.2004.04.374.

Download PDF

Reviewers agreed at journal
19 Sep, 2022
Reviewers invited by journal
19 Sep, 2022
Editor assigned by journal
17 Sep, 2022
First submitted to journal
15 Sep, 2022

You are reading this latest preprint version

A comparison of health-related factors between patients diagnosed with ME/CFS and patients with a related symptom picture but no ME/CFS diagnosis: A cross-sectional exploratory study

Status:

Version 1

Abstract

Figures

Background

Methods

ME/CFS diagnosis

Instruments

RAND-36

Statistical analysis

Results

Discussion

Conclusions

Abbreviations

Declarations

References

Status:

Version 1